Chapter No 7
Chapter No 7
7
CONCEPT OF
COMPARTMENT(S)MODELS:
There are three main reasons due to which the data is subjected to modelling.
1. Descriptive: to describe the drug kinetics in a simple way.
2. Predictive: to predict the time course of the drug after multiple dosing
based on single dose data, to predict the absorption profile of the drug
from the iv data.
3. Explanatory: to explain unclear observations.
PHARMACOKINETIC MODELING IS
USEFUL IN :-
• Prediction of drug concentration in plasma/ tissue/ urine at any point of
time.
• Determination of optimum dosage regimen for each patient.
• Estimation of the possible accumulation of drugs/ metabolites.
• Quantitative assessment of the effect of disease on drug’s adme.
• Correlation of drug concentration with pharmacological activity.
• Evaluation of bioequivalence.
TYPES OF PHARMACOKINETIC
MODELS
Mammillary model
Central compartment (comprises of plasma and highly perfused tissues such as lungs, liver,
kidneys) joined parallel to the peripheral compartment(comprises of less perfused organ) like
connection of satellites to a planet.
Catenary model
Compartments are joined to one another in a series like compartments of a train. This is however
not observable physiologically/anatomically as the various organs are directly linked to the
blood compartment.
ADVANTAGES
2. Rapid mixing
We also need to assume that the drug is mixed instantaneously in blood or plasma.
Within each compartment, the drug is considered to be rapidly and uniformly distributed i.e. the
compartment is well-stirred
3. Linear model
We will assume that drug elimination follows first order kinetics.
Other Assumptions
• Compartment is not a real physiologic or anatomic region but a fictitious or virtual one and
considered as a tissue or group of tissues that have similar drug distribution characteristics
(similar blood flow and affinity).
• The body is represented as a series of compartments arranged either in series or parallel to
each
other, that communicate reversibly with each other
PLASMA DRUG CONCENTRATION – TIME
PROFILE
Effectiveness of Dosage
Regimen
1. Central compartment
Blood & highly perfused tissues such as heart, kidney, lungs, liver, etc.
2. Peripheral compartment
Poorly per fused tissues such as fat, bone, etc.
MODELS:
“OPEN” and “CLOSED” models:
• The term “open” itself mean that, the administered drug dose is removed from
body by an excretory mechanism ( for most drugs, organs of excretion of drug is
kidney)
• If the drug is not removed from the body then model refers as “closed” model.
TYPES OF COMPARTMENTAL MODELS
Metabolism
Blood and KE
Ka
Drug other
body Output Excretion
Input (Elimination)
(Absorption) tissues
Blood and KE
other
body
tissues
ESTIMATION OF PHARMACOKINETIC
PARAMETERS
For a drug that follows one-compartment
kinetics and administered as rapid i.v. injection,
the decline in plasma drug concentration is only
due to elimination of drug from the body (and
not due to distribution), the phase being called
as elimination phase. Elimination phase can be
characterized by 3 parameters—
1. Elimination rate constant
2. Elimination half-life
3. Clearance
t1/ 2 …(11)
KE
0.693
The half – life is a secondary parameter that depends upon
the primary parameter clearance & apparent volume of
distribution.
According to following equation:
t1/ 0.693Vd …(12)
2 Cl T
APPARENT VOLUME OF DISTRIBUTION
Or
d x /d t
Cl
c
Clearance is defined as the theoretical volume of body fluid containing
drug from which the drug is completely removed in a given period of
time. It is expressed in ml/min or lit/hr.
TOTAL BODY CLEARANCE
Clearance at an individual organ level is called as organ clearance.
It can be estimated by dividing the rate of elimination by each organ
with the concentration of drug presented to it. Thus,
Renal clearance
…(17)
Cl R Rate of eliminatio n by
C
kidney
Hepatic clearance
…(18)
Rate of eliminatio n by
Cl C
liver
Other organ clearance
Since X/C = Vd ( from equation 13) the equ. (21) can be written
as …(22)
ClT K E
vd
TOTAL BODY CLEARANCE
Parallel equation can be written for renal and hepatic
clearance as:
ClR = Ke Vd
ClH= Km Vd
dx dx e v dx E …(1)
dt dt - dt
ONE-COMPARTMENT OPEN MODEL
EXTRAVASCULAR ADMINISTRATION
During the absorption phase, the rate absorption is greater than
the rate of elimination
dxev dx E …(2)
dt dt
At peak plasma concentration , the rate of absorption equals the
rate of elimination and the change in amount of drug in the body
is zero
dx dx …(3)
ev E
dt dt
The plasma level time curve is characterized only
Elimination
by the phase. …(4)
dx e v dx E
MULTI-
COMPARTME
NT MODELS
• Ideally a true pharmacokinetic model should be the one with a rate constant for
each tissue undergoing equilibrium.
• Therefore best approach is to pool together tissues on the basis of similarity in
their distribution characteristics.
• The drug disposition occurs by first order.
• Multi-compartment characteristics are best described by administration as i.v
bolus and observing the manner in which the plasma concentration declines with
time.
The no. Of exponentials required to describe such a plasma level-time profile
determines the no. Of kinetically homogeneous compartments into which a
drug will distribute.
The simplest and commonest is the two compartment model which classifies the
body tissues in two categories :
1. Central compartment or compartment
2. Peripheral or tissue compartment or compartment.
TWO COMPARTMENT OPEN MODEL-IV BOLUS
ADMINISTRATION:
Elimination from central compartment
Fig:
1 2
Central peripheral
• After the iv bolus of a drug the decline in the plasma conc. Is bi-
exponential.
• Two disposition processes- distribution and elimination.
• These two processes are only evident when a semi log plot of C vs. T is
made.
• Initially, the conc. Of drug in the central compartment declines rapidly, due
to the distribution of drug from the central compartment to the peripheral
compartment. This is called distributive phase.
TWO-COMPARTMENT OPEN MODEL
body tissues are broadly classified into 2 categories –
Central Compartment or Compartment 1
Comprising of blood and highly perfused tissues like
liver, lungs, kidneys, etc. that equilibrate with the
drug rapidly.
Elimination usually occurs from this compartment.
Depending upon the compartment from which the drug is eliminated, the two-compartment model
can be categorized into 3 types:
1.Two-compartment model with elimination from central compartment.
2.Two-compartment model with elimination from peripheral compartment.
3.Two-compartment model with elimination from both the compartments.
THREE COMPARTMENT
MODEL AND
APPLICATIONS OF
PHARMACOKINETIC
PARAMETERS IN DOSAGE
DETFELOPMENT
THREE COMPARTMENT MODEL
DEEP
CENTRAL TISSUE TISSUE
COMPARTMEN COMPARTMEN COMPARTM
T T ENT
K10
K21 K13
DEEP
TISSUE CENTRAL
TISSUE
COMPARTMEN COMPARTMEN
COMPARTMEN
T T K31 T
K12
DRUG OUTPUT
K10
iv
bolus i v bolus
Single oral
Dose
iv
infusion Oral
Intermittent i v infusion
drug
Multiple
REFERENCE BOOKS
• Biopharamaceutics and Clinical pharmacokinetics by Milo Gibaldi
• Applied biopharmaceutics and pharmacokinetics Textbook by Leon Shargel
• Pharmacokinetic-pharmacodynamic modeling and simulation Book by Peter
L. Bonate
• Essentials of Biopharmaceutics and Pharmacokinetics Book by Ashutosh
Kar
• Pharmacokinetics: Principles and Applications by Mehdi Boroujerdi
• Basic Pharmacokinetics by Mohsen A. Hedaya
• Clinical Pharmacokinetics: Concepts and Applications by Malcolm
Rowland, Thomas N. Tozer
• Biopharmaceutics and Pharmacokinetics Book by A. P. Pawar and J. S.
Kulkarni